Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
04.04. | Barrick Gold Corporation: Ben van Beurden and Pekka Vauramo Nominated for Election to Barrick Board of Directors | 501 | GlobeNewswire (Europe) | TORONTO, April 04, 2025 (GLOBE NEWSWIRE) -- Barrick Gold Corporation (NYSE:GOLD)(TSX:ABX) has nominated Ben van Beurden and Pekka Vauramo for election to its Board of Directors at the company's Annual... ► Artikel lesen | |
04.04. | Barrick Gold Corporation: Future-Focused Barrick Sets Sights on 30% Production Growth by 2030 | 924 | GlobeNewswire (Europe) | TORONTO, April 04, 2025 (GLOBE NEWSWIRE) -- Having laid the foundation to build the world's most valued gold and copper company, Barrick Gold Corporation (NYSE:GOLD)(TSX:ABX) is now advancing its... ► Artikel lesen | |
04.04. | Grupo Aeroportuario del Pacífico, S.A.B. de C.V.: Grupo Aeroportuario del Pacifico Reports in March 2025 a Passenger Traffic Increase of 5.6% Compared to 2024 | 127 | GlobeNewswire (Europe) | GUADALAJARA, Mexico, April 04, 2025 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V., (NYSE: PAC; BMV: GAP) ("the Company" or "GAP") announces preliminary terminal passenger traffic... ► Artikel lesen | |
04.04. | Pender Growth Fund Inc.: Pender Growth Fund Provides Financial Highlights and Company Updates | 83 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, April 04, 2025 (GLOBE NEWSWIRE) -- (TSXV: PTF) Pender Growth Fund Inc. (the "Company") today announced its financial and operational results for the year ended December... ► Artikel lesen | |
04.04. | Alumis Inc. and ACELYRIN, INC. File Joint Definitive Proxy Statement for Proposed Merger | 194 | GlobeNewswire (Europe) | Stockholders to benefit from differentiated late-stage portfolio of therapies and strong balance sheet Boards unanimously recommend stockholders vote "FOR" the merger Transaction expected to be completed... ► Artikel lesen | |
04.04. | Atlantic Petroleum P/F: Update on Debt | 143 | GlobeNewswire (Europe) | Tórshavn, Faroe Islands, 2025-04-04 (GLOBE NEWSWIRE) -- P/F Atlantic Petroleum (NASDAQ OMX: ATLA DKK) provides update on debt situation. Referring to the press release issued 31st March 2025 concerning... ► Artikel lesen | |
04.04. | Xilio Therapeutics, Inc.: Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 86 | GlobeNewswire (Europe) | WALTHAM, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies... ► Artikel lesen | |
04.04. | ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 92 | GlobeNewswire (Europe) | SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 04, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address... ► Artikel lesen | |
04.04. | Beyond Oil Ltd.: Beyond Oil Announces Distribution Agreement in the Netherlands with Mandarin Food Products | 192 | GlobeNewswire (Europe) | VANCOUVER, BC and KIBBUTZ YIFAT, Israel, April 04, 2025 (GLOBE NEWSWIRE) -- Beyond Oil Ltd. (CSE: BOIL) (OTCQB: BEOLF) (Frankfurt: UH9) ("Beyond Oil" or the "Company"), a food-tech innovation company... ► Artikel lesen | |
04.04. | Edesa Biotech, Inc.: Edesa Biotech Announces Chief Financial Officer Transition | 114 | GlobeNewswire (Europe) | TORONTO, April 04, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases... ► Artikel lesen | |
04.04. | Grayscale Investments Announces Rebalancing of Multi-Asset Funds for First Quarter 2025 | 139 | GlobeNewswire (Europe) | STAMFORD, Conn., April 04, 2025 (GLOBE NEWSWIRE) -- Grayscale Investments®, a leading crypto asset management firm, offering more than 30 crypto investment products, and manager of Grayscale® Digital... ► Artikel lesen | |
04.04. | CV Holdings, Inc. Update and Financial Statements for Year Ended December 31, 2024 | 91 | GlobeNewswire (Europe) | NEWPORT BEACH, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- CV Holdings, Inc. (OTC Pink Limited: CVHL) (the "Company") today reported a net loss for the year ended December 31, 2024 of $(18,153,285)... ► Artikel lesen | |
04.04. | Mersana Therapeutics, Inc.: Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 150 | GlobeNewswire (Europe) | CAMBRIDGE, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug... ► Artikel lesen | |
04.04. | Adverum Biotechnologies, Inc.: Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 87 | GlobeNewswire (Europe) | REDWOOD CITY, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum's Board of Directors granted an inducement... ► Artikel lesen | |
04.04. | Wintrust Financial Corporation Announces Cash Dividends | 138 | GlobeNewswire (Europe) | ROSEMONT, Ill., April 04, 2025 (GLOBE NEWSWIRE) -- Wintrust Financial Corporation ("Wintrust" or the "Company") (Nasdaq: WTFC) today announced that the Company's Board of Directors approved a quarterly... ► Artikel lesen | |
04.04. | Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 117 | GlobeNewswire (Europe) | BOSTON, April 04, 2025 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on March 31, 2025... ► Artikel lesen | |
04.04. | Cipher Mining Inc.: Cipher Mining Announces March 2025 Operational Update | 400 | GlobeNewswire (Europe) | NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- Cipher Mining Inc. (NASDAQ:CIFR) ("Cipher" or the "Company") today released its unaudited production and operations update for March 2025.Key HighlightsKey... ► Artikel lesen | |
04.04. | Syndax Pharmaceuticals, Inc.: Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | 91 | GlobeNewswire (Europe) | NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced... ► Artikel lesen | |
04.04. | Artius II Acquisition Inc. Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing April 7, 2025 | 101 | GlobeNewswire (Europe) | NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- Artius II Acquisition Inc. (Nasdaq:AACBU) (the "Company" or "Artius") announced that, commencing April 7, 2025, holders of the units sold in the Company's... ► Artikel lesen | |
04.04. | Associated Capital Group, Inc.: AC Reports Preliminary March 31 Book Value of $42.42 to $42.62 Per Share | 67 | GlobeNewswire (Europe) | GREENWICH, Conn., April 04, 2025 (GLOBE NEWSWIRE) -- Associated Capital Group, Inc. ("AC" or the "Company") (NYSE:AC), announced today a preliminary range for its first quarter book value of $42.42... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
NVIDIA | 3.015 |
APPLE | 2.123 |
STEYR MOTORS | 1.955 |
RHEINMETALL | 1.715 |
BYD | 1.535 |
RENK GROUP | 1.296 |
TESLA | 1.241 |
TUI | 1.191 |
DEUTZ | 1.102 |
NEL | 889 |
NOVO NORDISK | 734 |
EVOTEC | 729 |
INFINEON | 704 |
BASF | 669 |
BAYER | 625 |
MERCEDES-BENZ | 619 |
DEUTSCHE BANK | 610 |
XIAOMI | 600 |
MUTARES | 568 |
THYSSENKRUPP | 566 |
AMAZON | 555 |
COMMERZBANK | 555 |
DEUTSCHE TELEKOM | 555 |
ALLIANZ | 554 |
VOLKSWAGEN | 554 |